Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Kooi, A.J. van der"'
Autor:
Dam, K.P.J. van, Volkers, A.G., Wieske, L., Stalman, E.W., Kummer, L.Y.L., Kempen, Z.L.E. van, Killestein, J., Tas, S.W., Boekel, L., Wolbink, G.J., Kooi, A.J. van der, Raaphorst, J., Takkenberg, R.B., D'Haens, G.R.A.M.I., Spuls, P.W., Bekkenk, M.H., Musters, A.F., Post, N.L., Bosma, A.L., Hilhorst, M., Vegting, Y.J., Bemelman, F.E., Voskuyl, A., Broens, B., Sanchez, A.P., Els, C.A.C.M. van, Wit, J. de, Rutgers, A., Leeuw, K. de, Horvath, B., Verschuuren, J.J.G.M.M., Ruiter, A.M., Ouwerkerk, L. van, Woude, D. van der, Allaart, R.C.F., Teng, Y.K.O., Paassen, P.H. van, Busch, M.H., Jallah, P.B.P., Brusse, E., Doorn, P.A. van, Baars, A.E., Hijnen, D.J., Schreurs, C.R.G., Pol, W.L. van der, Goedee, H.S., Steenhuis, M., Keijzer, S., Keijser, J.B.D., Cristianawati, O., Brinke, A. ten, Verstegen, N.J.M., Ham, S.M. van, Rispens, T.W., Kuijpers, T., Lowenberg, M., Eftimov, F., TB2 Immunity Sars-Cov-2 Study Grp
Background: Patients with immune-mediated inflammatory diseases (IMIDs) on immunosuppressants (ISPs) may have impaired long-term humoral immune responses and increased disease activity after SARS-CoV-2 infection. We aimed to investigate long-term hum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::48e652b90d3e035b57aa8ad553b7a0eb
https://hdl.handle.net/1887/3630357
https://hdl.handle.net/1887/3630357
Autor:
Notarnicola, A., Hellstrom, C., Horuluoglu, B., Preger, C., Bonomi, F., Paepe, B. De, Bleecker, J. De, Kooi, A.J. van der, Visser, M de, Sacconi, S., Machado, P., Badrising, U.A., Rietveld, A., Pruijn, G., Rothwell, S., Lilleker, J.B., Chinoy, H., Benveniste, O., Svenungsson, E., Idborg, H., Jakobsson, P.J., Nilsson, P., Lundberg, I.E.
Publikováno v:
Annals of the Rheumatic Diseases, 82, Suppl 1, pp. 574.1-574
Annals of the Rheumatic Diseases, 82, 574.1-574
Annals of the Rheumatic Diseases, 82, 574.1-574
Contains fulltext : 293322.pdf (Publisher’s version ) (Closed access)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::cc7a48f9e99eb86e480522b54f72e0dc
https://repository.ubn.ru.nl/handle/2066/293322
https://repository.ubn.ru.nl/handle/2066/293322
Autor:
Volkov, M., Coppola, M., Huizinga, R., Eftimov, F., Huizinga, T.W.J., Kooi, A.J. van der, Oosten, L.E.M., Raaphorst, J., Rispens, T., Sciarrillo, R., Titulaer, M.J., Wieske, L., Toes, R.E.M., Huijbers, M.G.M., Schie, K.A. van, Woude, D. van der, T2B Consortium
Publikováno v:
T2B Consortium 2022, ' Comprehensive overview of autoantibody isotype and subclass distribution ', Journal of Allergy and Clinical Immunology, vol. 150, no. 5, pp. 999-1010 . https://doi.org/10.1016/j.jaci.2022.05.023
Journal of Allergy and Clinical Immunology, 150(5), 999-1010. MOSBY-ELSEVIER
Journal of Allergy and Clinical Immunology, 150(5), 999-1010. MOSBY-ELSEVIER
The presence of autoreactive antibodies is a hallmark of many autoimmune diseases. The effector functions of (auto)antibodies are determined by their constant domain, which defines the antibody isotype and subclass. The most prevalent isotype in seru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59192b959ff488b389e565b96a42d84b
https://hdl.handle.net/1887/3512518
https://hdl.handle.net/1887/3512518
Autor:
Stalman, E.W., Wieske, L., Dam, K.P.J. van, Kummer, L.Y., Kempen, Z.L.E. van, Killestein, J., Volkers, A.G., Tas, S.W., Boekel, L., Wolbink, G.J., Kooi, A.J. van der, Raaphorst, J., Lowenberg, M., Takkenberg, R.B., D'Haens, G.R.A.M., Spuls, P.I., Bekkenk, M.W., Musters, A.H., Post, N.F., Bosma, A.L., Hilhorst, M.L., Vegting, Y., Bemelman, F.J., Voskuyl, A.E., Broens, B., Sanchez, A.P., Els, C.A.C.M. van, Wit, J. de, Rutgers, A., Leeuw, K. de, Horvath, B., Verschuuren, J.J.G.M., Ruiter, A.M., Ouwerkerk, L. van, Woude, D. van der, Allaart, C.F., Teng, O.Y.K., Paassen, P. van, Busch, M.H., Jallah, P.B.P., Brusse, E., Doorn, P.A. van, Baars, A.E., Hijnen, D.J., Schreurs, C.R.G., Pol, W.L. van der, Goedee, H.S., Steenhuis, M., Keijzer, S., Keijser, J.B.D., Boogaard, A., Cristianawati, O., Brinke, A. ten, Verstegen, N.J.M., Zwinderman, K.A.H., Rispens, T., Ham, S.M. van, Kuijpers, T.W., Eftimov, F., T2B Immunity Against SARS Co
Publikováno v:
Annals of the Rheumatic Diseases, 81(12):222904, 1757-1766. BMJ Publishing Group
Annals of the rheumatic diseases, 81(12):222904, 1757-1766. BMJ Publishing Group
Annals of the Rheumatic Diseases, 81, 1757-1766. BMJ PUBLISHING GROUP
Annals of the Rheumatic Diseases, 81(12), 1757-1766. BMJ Publishing Group
Stalman, E W, Wieske, L, van Dam, K P J, Kummer, L Y, van Kempen, Z L E, Killestein, J, Volkers, A G, Tas, S W, Boekel, L, Wolbink, G J, van der Kooi, A J, Raaphorst, J, Löwenberg, M, Takkenberg, R B, D'Haens, G R A M, Spuls, P I, Bekkenk, M W, Musters, A H, Post, N F, Bosma, A L, Hilhorst, M L, Vegting, Y, Bemelman, F J, Voskuyl, A E, Broens, B, Parra Sanchez, A, van Els, C C A C M, Wit, J D, Rutgers, A, de Leeuw, K, Horváth, B, Verschuuren, J J G M, Ruiter, A M, van Ouwerkerk, L, van der Woude, D, Allaart, C F, Teng, O Y K, van Paassen, P, Busch, M H, Jallah, P B P, Brusse, E, van Doorn, P A, Baars, A E, Hijnen, D J, Schreurs, C R G, van der Pol, W L, Goedee, H S, Steenhuis, M, Keijzer, S, Keijser, J B D, Boogaard, A, Cristianawati, O, ten Brinke, A, Verstegen, N J M, Zwinderman, K A H, Rispens, T, van Ham, S M, Kuijpers, T W & Eftimov, F 2022, ' Breakthrough infections with the SARS-CoV-2 omicron (B.1.1.529) variant in patients with immune-mediated inflammatory diseases ', Annals of the Rheumatic Diseases, vol. 81, no. 12, 222904, pp. 1757-1766 . https://doi.org/10.1136/ard-2022-222904
Annals of the Rheumatic Diseases, 81(12). BMJ PUBLISHING GROUP
Annals of the rheumatic diseases, 81(12):222904, 1757-1766. BMJ Publishing Group
Annals of the Rheumatic Diseases, 81, 1757-1766. BMJ PUBLISHING GROUP
Annals of the Rheumatic Diseases, 81(12), 1757-1766. BMJ Publishing Group
Stalman, E W, Wieske, L, van Dam, K P J, Kummer, L Y, van Kempen, Z L E, Killestein, J, Volkers, A G, Tas, S W, Boekel, L, Wolbink, G J, van der Kooi, A J, Raaphorst, J, Löwenberg, M, Takkenberg, R B, D'Haens, G R A M, Spuls, P I, Bekkenk, M W, Musters, A H, Post, N F, Bosma, A L, Hilhorst, M L, Vegting, Y, Bemelman, F J, Voskuyl, A E, Broens, B, Parra Sanchez, A, van Els, C C A C M, Wit, J D, Rutgers, A, de Leeuw, K, Horváth, B, Verschuuren, J J G M, Ruiter, A M, van Ouwerkerk, L, van der Woude, D, Allaart, C F, Teng, O Y K, van Paassen, P, Busch, M H, Jallah, P B P, Brusse, E, van Doorn, P A, Baars, A E, Hijnen, D J, Schreurs, C R G, van der Pol, W L, Goedee, H S, Steenhuis, M, Keijzer, S, Keijser, J B D, Boogaard, A, Cristianawati, O, ten Brinke, A, Verstegen, N J M, Zwinderman, K A H, Rispens, T, van Ham, S M, Kuijpers, T W & Eftimov, F 2022, ' Breakthrough infections with the SARS-CoV-2 omicron (B.1.1.529) variant in patients with immune-mediated inflammatory diseases ', Annals of the Rheumatic Diseases, vol. 81, no. 12, 222904, pp. 1757-1766 . https://doi.org/10.1136/ard-2022-222904
Annals of the Rheumatic Diseases, 81(12). BMJ PUBLISHING GROUP
ObjectivesTo compare the cumulative incidence and disease severity of reported SARS-CoV-2 omicron breakthrough infections between patients with immune-mediated inflammatory diseases (IMID) on immunosuppressants and controls, and to investigate determ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19dc8c343aa3a7c58690faa029528df1
https://pure.eur.nl/en/publications/95be4c3a-8d51-4bec-a116-f9d40c9a985a
https://pure.eur.nl/en/publications/95be4c3a-8d51-4bec-a116-f9d40c9a985a
Autor:
Doets, A.Y., Lingsma, H.F., Walgaard, C., Islam, B., Papri, N., Davidson, A., Yamagishi, Y., Kusunoki, S., Dimachkie, M.M., Waheed, W., Kolb, N., Islam, Z., Mohammad, Q.D., Harbo, T., Sindrup, S.H., Chavada, G., Willison, H.J., Casasnovas, C., Bateman, K., Miller, J.A.L., Berg, B. van den, Verboon, C., Roodbol, J., Leonhard, S.E., Benedetti, L., Kuwabara, S., Bergh, P. van den, Monges, S., Marfia, G.A., Shahrizaila, N., Galassi, G., Pereon, Y., Burmann, J., Kuitwaard, K., Kleyweg, R.P., Marchesoni, C., Tous, M.J.S., Querol, L., Illa, I., Wang, Y.Z., Nobile-Orazio, E., Rinaldi, S., Schenone, A., Pardo, J., Vermeij, F.H., Lehmann, H.C., Granit, V., Cavaletti, G., Gutierrez-Gutierrez, G., Barroso, F.A., Visser, L.H., Katzberg, H.D., Dardiotis, E., Attarian, S., Kooi, A.J. van der, Eftimov, F., Wirtz, P.W., Samijn, J.P.A., Gilhuis, H.J., Hadden, R.D.M., Holt, J.K.L., Sheikh, K.A., Karafiath, S., Vytopil, M., Antonini, G., Feasby, T.E., Faber, C.G., Gijsbers, C.J., Busby, M., Roberts, R.C., Silvestri, N.J., Fazio, R., Dijk, G.W. van, Garssen, M.P.J., Straathof, C.S.M., Gorson, K.C., Jacobs, B.C., IGOS Consortium
Publikováno v:
Neurology, 98(5), E518-E532. Lippincott Williams and Wilkins
Neurology, 98(5), E518-E532. LIPPINCOTT WILLIAMS & WILKINS
Neurology, 98(5), E518-E532. Lippincott Williams & Wilkins
Doets, A Y, Lingsma, H F, Walgaard, C, Islam, B, Papri, N, Davidson, A, Yamagishi, Y, Kusunoki, S, Dimachkie, M M, Waheed, W, Kolb, N, Islam, Z, Mohammad, Q D, Harbo, T, Sindrup, S H, Chavada, G, Willison, H J, Casasnovas, C, Bateman, K, Miller, J A L, van den Berg, B, Verboon, C, Roodbol, J, Leonhard, S E, Benedetti, L, Kuwabara, S, van den Bergh, P, Monges, S, Marfia, G A, Shahrizaila, N, Galassi, G, Péréon, Y, Bürmann, J, Kuitwaard, K, Kleyweg, R P, Marchesoni, C, Sedano Tous, M J, Querol, L, Illa, I, Wang, Y, Nobile-Orazio, E, Rinaldi, S, Schenone, A, Pardo, J, Vermeij, F H, Lehmann, H C, Granit, V, Cavaletti, G, Gutiérrez-Gutiérrez, G, Barroso, F A & the IGOS consortium 2022, ' Predicting Outcome in Guillain-Barré Syndrome : International Validation of the Modified Erasmus GBS Outcome Score ', Neurology, vol. 98, no. 5, pp. E518-E532 . https://doi.org/10.1212/WNL.0000000000013139
Doets, A Y, Lingsma, H F, Walgaard, C, Islam, B, Papri, N, Davidson, A, Yamagishi, Y, Kusunoki, S, Dimachkie, M M, Waheed, W, Kolb, N, Islam, Z, Mohammad, Q D, Harbo, T, Sindrup, S H, Chavada, G, Willison, H J, Casasnovas, C, Bateman, K, Miller, J A L, van den Berg, B, Verboon, C, Roodbol, J, Leonhard, S E, Benedetti, L, Kuwabara, S, van den Bergh, P, Monges, S, Marfia, G A, Shahrizaila, N, Galassi, G, Péréon, Y, Bürmann, J, Kuitwaard, K, Kleyweg, R P, Marchesoni, C, Sedano Tous, M J, Querol, L, Illa, I, Wang, Y, Nobile-Orazio, E, Rinaldi, S, Schenone, A, Pardo, J, Vermeij, F H, Lehmann, H C, Granit, V, Cavaletti, G, Gutiérrez-Gutiérrez, G, Barroso, F A & the IGOS Consortium 2022, ' Predicting Outcome in Guillain-Barré Syndrome International Validation of the Modified Erasmus GBS Outcome Score ', Neurology, vol. 98, no. 5, pp. E518-E532 . https://doi.org/10.1212/WNL.0000000000013139
Neurology
Neurology, 98(5), E518-E532. LIPPINCOTT WILLIAMS & WILKINS
Neurology, 98(5), E518-E532. Lippincott Williams & Wilkins
Doets, A Y, Lingsma, H F, Walgaard, C, Islam, B, Papri, N, Davidson, A, Yamagishi, Y, Kusunoki, S, Dimachkie, M M, Waheed, W, Kolb, N, Islam, Z, Mohammad, Q D, Harbo, T, Sindrup, S H, Chavada, G, Willison, H J, Casasnovas, C, Bateman, K, Miller, J A L, van den Berg, B, Verboon, C, Roodbol, J, Leonhard, S E, Benedetti, L, Kuwabara, S, van den Bergh, P, Monges, S, Marfia, G A, Shahrizaila, N, Galassi, G, Péréon, Y, Bürmann, J, Kuitwaard, K, Kleyweg, R P, Marchesoni, C, Sedano Tous, M J, Querol, L, Illa, I, Wang, Y, Nobile-Orazio, E, Rinaldi, S, Schenone, A, Pardo, J, Vermeij, F H, Lehmann, H C, Granit, V, Cavaletti, G, Gutiérrez-Gutiérrez, G, Barroso, F A & the IGOS consortium 2022, ' Predicting Outcome in Guillain-Barré Syndrome : International Validation of the Modified Erasmus GBS Outcome Score ', Neurology, vol. 98, no. 5, pp. E518-E532 . https://doi.org/10.1212/WNL.0000000000013139
Doets, A Y, Lingsma, H F, Walgaard, C, Islam, B, Papri, N, Davidson, A, Yamagishi, Y, Kusunoki, S, Dimachkie, M M, Waheed, W, Kolb, N, Islam, Z, Mohammad, Q D, Harbo, T, Sindrup, S H, Chavada, G, Willison, H J, Casasnovas, C, Bateman, K, Miller, J A L, van den Berg, B, Verboon, C, Roodbol, J, Leonhard, S E, Benedetti, L, Kuwabara, S, van den Bergh, P, Monges, S, Marfia, G A, Shahrizaila, N, Galassi, G, Péréon, Y, Bürmann, J, Kuitwaard, K, Kleyweg, R P, Marchesoni, C, Sedano Tous, M J, Querol, L, Illa, I, Wang, Y, Nobile-Orazio, E, Rinaldi, S, Schenone, A, Pardo, J, Vermeij, F H, Lehmann, H C, Granit, V, Cavaletti, G, Gutiérrez-Gutiérrez, G, Barroso, F A & the IGOS Consortium 2022, ' Predicting Outcome in Guillain-Barré Syndrome International Validation of the Modified Erasmus GBS Outcome Score ', Neurology, vol. 98, no. 5, pp. E518-E532 . https://doi.org/10.1212/WNL.0000000000013139
Neurology
Background and ObjectivesThe clinical course and outcome of the Guillain-Barré syndrome (GBS) are diverse and vary among regions. The modified Erasmus GBS Outcome Score (mEGOS), developed with data from Dutch patients, is a clinical model that predi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37779cf9507298a6202d42c62178d160
https://hdl.handle.net/1887/3495929
https://hdl.handle.net/1887/3495929
Autor:
Straathof, C.S., Heusden, D. Van, Ippel, P.F., Post, J.G., Voermans, N.C., Visser, M. de, Brusse, E., Bergen, J.C. van den, Kooi, A.J. van der, Verschuuren, J.J., Ginjaar, H.B.
Publikováno v:
Muscle & nerve, 53(1), 44-48. John Wiley and Sons Inc.
Muscle & Nerve, 53(1), 44. John Wiley and Sons Inc.
Muscle and Nerve, 53, 44-8
Muscle & Nerve, 53(1), 44-48. John Wiley & Sons Inc.
Muscle and Nerve, 53, 1, pp. 44-8
Muscle & Nerve, 53(1), 44. John Wiley and Sons Inc.
Muscle and Nerve, 53, 44-8
Muscle & Nerve, 53(1), 44-48. John Wiley & Sons Inc.
Muscle and Nerve, 53, 1, pp. 44-8
Item does not contain fulltext INTRODUCTION: The phenotype of Becker muscular dystrophy (BMD) is highly variable, and the disease may be underdiagnosed. We searched for new mutations in the DMD gene in a cohort of previously undiagnosed patients who
Autor:
Westrum, S.M.S. van, Dekker, L.R.C., Voogt, W.G. de, Wilde, A.A.M., Ginjaar, I.B., Visser, M. de, Kooi, A.J. van der
Publikováno v:
Muscle and Nerve, 50(6), 909-913
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::3817fdc5128943f87eef74476258938c
http://hdl.handle.net/1887/105013
http://hdl.handle.net/1887/105013
Autor:
Straathof, C.S.M., Heusden, D. van, Ippel, P.F., Post, J.G., Voermans, N.C., Visser, M. de, Brusse, E., Bergen, J.C. van den, Kooi, A.J. van der, Verschuuren, J.J.G., Ginjaar, H.B.
Publikováno v:
Neuromuscular Disorders, 24(9-10), 794-794
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::cb573280cb5fac817d4adb7e62fdb26e
https://hdl.handle.net/1887/107041
https://hdl.handle.net/1887/107041
Autor:
Bergen, J.C. van den, Wokke, B.H.A., Damme, P. van, Kooi, A.J. van der, Bleecker, J. de, Jonghe, P. de, Verschuuren, J.J.
Publikováno v:
Neuromuscular Disorders, 24(9-10), 795-795
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::c9d88671146aee06073a49f662254a67
https://hdl.handle.net/1887/104039
https://hdl.handle.net/1887/104039
Autor:
Doormaal, P.T. van, Rheenen, W. van, Blitterswijk, M. van, Schellevis, R.D., Schelhaas, H.J., Visser, M. de, Kooi, A.J. van der, Veldink, J.H., Berg, L.H. van den
Publikováno v:
Neurobiology of Aging, 33, 9, pp. 2233.e7-2233.e8
Neurobiology of Aging, 33, 2233.e7-2233.e8
Neurobiology of Aging, 33, 2233.e7-2233.e8
Item does not contain fulltext Recently it was discovered that mutations in the UBQLN2 gene were a cause of an X-linked dominant type of familial amyotrophic lateral sclerosis (ALS). We investigated the frequency of mutations in this gene in a cohort
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::e8ad91c3453a3781b53524ee1ca0e9ad
https://hdl.handle.net/2066/110084
https://hdl.handle.net/2066/110084